Medicus Pharma Ltd Announces Positively Trending Interim Analysis for SKNJCT-003 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

Seeking Alpha / 1 hour ago 1 Views

The Interim Analysis Showed Complete Clinical Clearance of More Than Sixty (60%) Percent 
The Interim Analysis Showed Complete Clinical Clearance of More Than Sixty (60%) Percent
Read more

Comments